- Home
- LGVN vs NTBL Comparison
LGVN vs NTBL Comparison
Compare LGVN & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- NTBL
- Stock Information
- Founded
- LGVN 2014
- NTBL 2000
- Country
- LGVN United States
- NTBL United States
- Employees
- LGVN N/A
- NTBL N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- NTBL Health Care
- Exchange
- LGVN Nasdaq
- NTBL Nasdaq
- Market Cap
- LGVN 30.0M
- NTBL 4.6M
- IPO Year
- LGVN 2021
- NTBL N/A
- Fundamental
- Price
- LGVN $2.05
- NTBL $0.25
- Analyst Decision
- LGVN Strong Buy
- NTBL Buy
- Analyst Count
- LGVN 2
- NTBL 2
- Target Price
- LGVN $8.00
- NTBL $5.00
- AVG Volume (30 Days)
- LGVN 393.9K
- NTBL 8.1M
- Earning Date
- LGVN 11-08-2024
- NTBL 11-12-2024
- Dividend Yield
- LGVN N/A
- NTBL N/A
- EPS Growth
- LGVN N/A
- NTBL N/A
- EPS
- LGVN N/A
- NTBL N/A
- Revenue
- LGVN $1,229,000.00
- NTBL $313,000.00
- Revenue This Year
- LGVN $161.78
- NTBL N/A
- Revenue Next Year
- LGVN $8.62
- NTBL N/A
- P/E Ratio
- LGVN N/A
- NTBL N/A
- Revenue Growth
- LGVN 39.34
- NTBL 3812.50
- 52 Week Low
- LGVN $0.77
- NTBL $0.22
- 52 Week High
- LGVN $23.90
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- LGVN 52.20
- NTBL 35.14
- Support Level
- LGVN $1.76
- NTBL $0.28
- Resistance Level
- LGVN $2.26
- NTBL $0.37
- Average True Range (ATR)
- LGVN 0.12
- NTBL 0.06
- MACD
- LGVN 0.05
- NTBL -0.01
- Stochastic Oscillator
- LGVN 58.00
- NTBL 6.26
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.